A new analysis suggests that people with type 2 diabetes who use GLP-1 medications like Ozempic, Trulicity or Victoza may be ...

Ozempic has hit the Indian market and will be available at Rs 2,200 per week. But did you know that there are alternatives ...

Popular GLP-1 medications such as Ozempic may carry an unexpected link to a lower risk of epilepsy in people with type 2 ...

A federal judicial panel said Monday it would centralize a growing number of lawsuits against Novo Nordisk and Eli Lilly ...

Judges allow consolidation of vision loss lawsuits filed against Novo Nordisk and Eli Lilly over diabetes and weight loss ...

Australia’s drug regulator, Therapeutic Goods Administration, has issued a new safety warning for Ozempic and similar weight-loss and diabetes drugs, citing possible links to suicidal thoughts and ...

There is no exact known number of GLP-1 patients who say their say their sense of taste has changed since starting the ...

Australia's Therapeutic Goods Administration has issued new safety warnings about mental health risks and contraception concerns for certain diabetes and weight-loss medications.

WASHINGTON – For 14 years, Jesse’s mind spiraled. So did his weight. The medications he took for schizophrenia drove his weight up until he nearly hit the 300-pound mark. His mom wanted to get him on ...

While the WHO study saw reports of suicidal thoughts were slightly higher for semaglutide in particular, the warning applies for all GLP-1s, including Saxenda, Trulicity and Mounjaro. Semaglutide is ...

GLP-1 receptor agonists were tied to a 16% lower risk of epilepsy in adults with type 2 diabetes. Epilepsy is an ...

Australia’s TGA has issued updated safety warnings for GLP-1 drugs like Ozempic and Mounjaro, highlighting mental-health ...